Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Identification and biochemical characterization of antigens of tachyzoites and bradyzoites ofToxoplasma gondii with cross-reactive epitopes

Abstract

The aim of the present work was the identification and biochemical characterization of antigens from the tachyzoite and bradyzoite stages ofToxoplasma gondii that share cross-reactive epitopes. Our previous work has demonstrated the induction by tachyzoite excreted-secreted antigens of both a humoral and a cell-mediated protective response. We investigated the question as to whether some bradyzoite and tachyzoite (excreted-secreted, soluble or membrane) antigens share cross-reactive epitopes. Using immunoprecipitation techniques, we identified four tachyzoite antigens with molecular weights of 63, 43, 39, and 28.5 kDa, which were recognized by sera raised against bradyzoite extracts. We also detected a 43-kDa bradyzoite antigen that was recognized both by sera raised against tachyzoite antigens and by chronic-phase human sera with residual IgG antibodies. In an attempt to define the biochemical nature of these antigens, we show that the 43- and 28.5-kDa antigens seem to be glycosylated since they bind to concanavalin A, as does a 37-kDa tachyzoite antigen.

This is a preview of subscription content, log in to check access.

References

  1. Capron A, Dessaint JP (1988) Vaccination against parasitic diseases: some alternative concepts for the definition of protective antigens. Ann Inst Pasteur Immunol 139:109–117

  2. Cesbron-Delauw MF, Guy B, Torpier G, Pierce RJ, Lenzen G, Cesbron JY, Charif H, Lepage P, Darcy F, Lecocq JP, Capron A (1989) Molecular characterization of a 23-kilodalton major antigen secreted byToxoplasma gondii. Proc Natl Acad Sci USA 86:7537–7541

  3. Charif H, Darcy F, Torpier G, Cesbron-Delauw MF, Capron A (1990)Toxoplasma gondii: Characterization and Localization of Antigens Secreted from Tachyzoites. Exp Parasitol 71 (in press)

  4. Couvreur G, Sadak A, Fortier B, Dubremetz JF (1988) Surface antigens ofToxoplasma gondii. Parasitology 97:1–10

  5. Darcy F, Deslée D, Santoro F, Charif H, Auriault C, Decoster A, Duquesne V, Capron A (1988) Induction of a protective antibody-dependent response against toxoplasmosis by in vitro excreted/secreted antigens from tachyzoites ofToxoplasma gondii. Parasite Immunol 10:553–567

  6. Decoster A, Darcy F, Capron A (1988) Recognition ofToxoplasma gondii excreted and secreted antigens by human sera from acquired and congenital toxoplasmosis: identification of markers of acute and chronic infection. Clin Exp Immunol 73:376–382

  7. Desmonts G, Couvreur J (1974) Toxoplasmosis and the pregnant woman. In: Extrait des Actualités Gynécologiques, 4th edn. Masson et Cie, Paris, pp 101–111

  8. Frenkel JK (1988) Pathophysiology of toxoplasmosis. Parasitol Today 4:273–278

  9. Frenkel JK, Nelson BM, Arias-Stella J (1975) Immunosuppression and toxoplasmic encephalitis. Clin Exp Aspects Hum Pathol 6:97–111

  10. Handman E, Goding JW, Remington JS (1980) Detection and characterization of membrane antigens ofToxoplasma gondii. J Immunol 124:2578–2583

  11. Howard RJ, Kaushal DC, Carter R (1982) Radioiodination of parasite antigens with 1,3,4,6-tetrachloro-3,6-diphenylglycoluril (Iodogen). Studies with zygotes ofPlasmodium gallinaceum. J Protozool 29:114–117

  12. Hughes HPA (1985) Toxoplasmosis: the need for improved diagnostic techniques and accurate risk assessment. Curr Top Microbiol Immunol 120:105–139

  13. Huldt G (1971) Studies on experimental toxoplasmosis. Ann NY Acad Sci 177:146–155

  14. Hunter WM, Greenwood FC (1962) Preparation of iodine 131-labelled human growth hormone of high specific activity. Nature 194:495–496

  15. Johnson AM (1985) The antigenic structure ofToxoplasma gondii: a review. Pathology 17:9–19

  16. Johnson AM, McDonald PJ, Neoh SH (1981) Molecular weight analysis of the major polypeptides and glycoproteins ofToxoplasma gondii. Biochem Biophys Res Commun 100:934–943

  17. Johnson AM, Haynes WD, Leppard PJ, McDonald PJ, Neoh SH (1983) Ultrastructural and biochemical studies on the immunohistochemistry ofToxoplasma gondii antigens using monoclonal antibodies. Histochemistry 177:209–215

  18. Kasper LH (1989) Identification of stage specific antigens ofToxoplasma gondii. Infect Immun 57:668–672

  19. Kasper LH, Ware PL (1985) Recognition and characterization of stage-specific oocyst/sporozoite antigens ofToxoplasma gondii by human antisera. J Clin Invest 75:1570–1577

  20. Kasper LH, Crabb JH, Pfefferkorn ER (1982) Purification of a major membrane protein ofToxoplasma gondii by immunoabsorption with a monoclonal antibody. J Immunol 130:2407–2412

  21. Kasper LH, Crabb JH, Pfefferkorn ER (1983) Isolation and characterization of monoclonal antibody-resistant antigenic mutants ofToxoplasma gondii. J Immunol 129:1696–1699

  22. Kasper LH, Bradley MS, Pfefferkorn ER (1984) Identification of stage-specific sporozoite antigens ofToxoplasma gondii by monoclonal antibodies. J Immunol 132:443–449

  23. Kasper LH, Currie KM, Bradley MS (1985) An unexpected response to vaccination with a purified major membrane tachyzoite antigen (P30) ofToxoplasma gondii. J Immunol 134:3426–3431

  24. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685

  25. Laugier M, Quilici M (1970) Intérêt expérimental d'une souche de toxoplasme peu pathogène pour la souris. Ann Parasitol Hum Comp 45:389–403

  26. Lunde MN, Jacobs L (1983) Antigenic differences between endozoites and cystozoites ofToxoplasma gondii. J Parasitol 69:806–808

  27. Mauras G, Dodeur M, Laget P, Senet JH, Bourrillon R (1980) Partial resolution of the sugar content ofToxoplasma gondii membrane. Biochem Biophys Res Commun 97:906–912

  28. McCabe R, Remington JS (1988) Toxoplasmosis: the time has come. N Engl J Med 318:313–314

  29. Nakabayashi T, Motomura I (1968) A method for separating cysts ofToxoplasma gondii from infected mouse brains by multilayer centrifugation with gum arabic solution. Trop Med 10:72–80

  30. Naot Y, Guptill DR, Mullenax J, Remington JS (1983) Characterization ofToxoplasma gondii antigens that react with human immunoglobulin M and immunoglobulin G antibodies. Infect Immun 41:331–338

  31. Remington JS (1968) Toxoplasmosis and congenital infection In Intrauterine infections, birth defects. Original Article Series 4. The National Foundation, March of Dimes, New York, pp 47–56

  32. Remington JS (1974) Toxoplasmosis in the adult. Bull NY Acad Med 50:211–227

  33. Remington JS, Krahenbuhl JL (1982) Immunology ofToxoplasma gondii. In: Nahamias AJ, O'Reilly RJ (eds) Comprehensive immunology. Plenum, New York London, pp 327–371

  34. Ridel PR, Auriault C, Darcy F, Pierce RJ, Leite P, Santoro F, Neyrinek JL, Kusnierz JP, Capron A (1988) Protective role of IgE in immunocompromised rat toxoplasmosis. J Immunol 141:978–983

  35. Sadak A, Taghy Z, Fortier B, Dubremetz JF (1988) Characterization of a family of rhoptry proteins ofToxoplasma gondii. Mol Biochem Parasitol 29:203–211

  36. Sethi KK, Rahman A, Pelster B, Brandis H (1977) Search for the presence of lectin-binding sites onToxoplasma gondii. J Parasitol 63:1076–1080

  37. Sharma SD, Mullenax J, Araujo FG, Erlich HA, Remington JS (1983) Western blot analysis of the antigens ofToxoplasma gondii recognized by human IgM and IgG antibodies. J Immunol 131:977–983

  38. Sibley LD, Krahenbuhl JL, Adams GMW, Weidner E (1986)Toxoplasma modifies macrophage phagosomes by secretion of a vesicular network rich in surface proteins. J Cell Biol 103:867–874

Download references

Author information

Correspondence to F. Darcy.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Darcy, F., Charif, H., Caron, H. et al. Identification and biochemical characterization of antigens of tachyzoites and bradyzoites ofToxoplasma gondii with cross-reactive epitopes. Parasitol Res 76, 473–478 (1990). https://doi.org/10.1007/BF00931052

Download citation

Keywords

  • Molecular Weight
  • Biochemical Characterization
  • Concanavalin
  • Protective Response
  • Human Seron